Rapid Dose Therapeutics Corp. reported earnings results for the second quarter and six months ended August 31, 2023. For the second quarter, the company reported sales was CAD 0.353171 million compared to CAD 0.133554 million a year ago. Net loss was CAD 0.730685 million compared to CAD 0.91452 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
For the six months, sales was CAD 0.593958 million compared to CAD 0.19532 million a year ago. Net loss was CAD 1.3 million compared to CAD 1.92 million a year ago. Basic loss per share from continuing operations was CAD 0.01.